[Comparison of epirubicin and cyclophosphamide in 2-dose levels and classical CMF protocol in node-positive breast cancer. An adjuvant Phase III trial].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples